RecruitingPhase 2NCT02015013

Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Studying Idiopathic CD4 lymphocytopenia

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Principal Investigator: Irini Sereti, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Intervention: Filgrastim(biological)
Enrollment: 40 target
Eligibility: 18-65 years · All sexes
Timeline: 2014 – 2026

Study locations (1)

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02015013 on ClinicalTrials.gov

Other trials for Idiopathic CD4 lymphocytopenia

Additional recruiting or active studies for the same condition.

RECRUITINGNCT00867269
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID)

See all trials for Idiopathic CD4 lymphocytopenia →

← Back to all trials